Alios Biopharma
South San Francisco, US
Biotech
Founders & leadership
PH
Peter HirthNamed on SEC filing
JN
Jack NielsenNamed on SEC filing
CM
Campbell MurrayNamed on SEC filing
LB
Lawrence BlattNamed on SEC filing
JD
John DonovanNamed on SEC filing
LB
Leonid BeigelmanNamed on SEC filing
JE
Jens EcksteinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$41M disclosed across 1 round · 2014
▶$41MraisedMay 2014 · 14 investors · PharmaceuticalsRule 506(b)
▶$41MraisedMay 2014 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter HirthDirector
- Jack NielsenDirector
- Campbell MurrayDirector
- Lawrence BlattExecutive Officer, Director
- John DonovanExecutive Officer
- Leonid BeigelmanExecutive Officer
- Jens EcksteinDirector
- Offering amount
- $41M
- Amount sold
- $41M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Alios Biopharma raised?
- Alios Biopharma has disclosed $41M raised across 1 round.
- Where is Alios Biopharma headquartered?
- Alios Biopharma is headquartered in South San Francisco, US.